Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effectMin Gao, Lawrence G. Hamann, Julie A. Lemm et al.|Nature|2010Cited by 940
Characterizations of HCV NS5A replication complex inhibitorsDonald R. O’Boyle, Min Gao, Jin-Hua Sun et al.|Virology|2013Cited by 49
HCV NS5A Replication Complex Inhibitors. Part 4.1 Optimization for Genotype 1a Replicon Inhibitory ActivityDenis R. St. Laurent, Lawrence B. Snyder, Michael H. Serrano‐Wu et al.|Journal of Medicinal Chemistry|2013Cited by 35
HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologiesOmar D. Lopez, Lawrence B. Snyder, Van N. Nguyen et al.|Bioorganic & Medicinal Chemistry Letters|2012Cited by 29
HCV NS5A replication complex inhibitors. Part 2: Investigation of stilbene prolinamidesDenis R. St. Laurent, Lawrence B. Snyder, Makonen Belema et al.|Bioorganic & Medicinal Chemistry Letters|2012Cited by 27